Get started
Author

Nalini Devi Verusingam

Observed names: Devi Verusingam Nalini, N. Verusingam, Verusingam, Nalini Devi
ORCID: 0000-0002-2232-0502
Observed ORCID: 0000-0002-2232-0502
OpenAlex ID: A5036273159
Circular RNAs Modulate Cancer Hallmark and Molecular Pathways to Support Cancer Progression and Metastasis
2022 · Aliaksandr A. Yarmishyn, Afeez Adekunle Ishola, et al. · Cancers · 28
PDF
Single-cell RNA sequencing in human lung cancer: Applications, challenges, and pathway towards personalized therapy
2021 · Zhi-Xiong Chong, Wan-Yong Ho, et al. · Journal of the Chinese Medical Association · 14
Generation of osimertinib-resistant cells from epidermal growth factor receptor L858R/T790M mutant non-small cell lung carcinoma cell line
2020 · Nalini Devi Verusingam, Yi-Chen Chen, et al. · Journal of the Chinese Medical Association · 13
Current trends and promising clinical utility of IPSC-derived MSC (iMSC)
2023 · Shih-Hwa Chiou, Han Kiat Alan Ong, et al. · Progress in molecular biology and translational science · 10
Susceptibility of Human Oral Squamous Cell Carcinoma (OSCC) H103 and H376 cell lines to Retroviral OSKM mediated reprogramming
2017 · Nalini Devi Verusingam, Swee Keong Yeap, et al. · PeerJ · 9
CircSPINT2 confers sensitivity to osimertinib via hsa-miR-1296-3p/RBP1 axis and inhibits NSCLC progression
2025 · Nalini Devi Verusingam, Aliaksandr A. Yarmishyn, et al. · Molecular Therapy Oncology · 5
RNA therapeutic targeting of recalcitrant and rare cancers
2026 · Afeez Adekunle Ishola, Nalini Devi Verusingam, et al. · Exploration of Targeted Anti-tumor Therapy
PDF
Abstract 3348: Identification of circSPINT2 as a tumor suppressive circular RNA sensitizing lung cancer to 3rd generation EGFR-TKI treatment
2024 · Mong-Lien (Lotus) Wang, Shih-Hwa Shiou, et al. · Cancer Research
Epithelial-Mesenchymal Transition (EMT) deregulation in reprogrammed Oral Squamous Cell Carcinoma (OSCC-iPSCs)
2018 · Verusingam, Nalini Devi, Yeap, Swee Keong, et al. · Asian Journal of Medicine and Biomedicine
PDF
Induced Pluripotent Stem Cells (IPSCs) Line Derived from H103—Orals Squamous Cell Carcinoma (OSCC) Cells
2016 · N. Verusingam, S. Yeap, et al. · Cytotherapy
Development and Characterization of Induced Pluripotent Cells (IPSCS) Derived from Human Oral Squamous Carcinoma Cell (OSCC)
2015 · Devi Verusingam Nalini
Works count: 11
Citation count: 79
H-index: 5
I10-index: 4
Year
Topic
Type